- Report
- December 2024
- 321 Pages
Global
From €1702EUR$1,859USD£1,447GBP
€2432EUR$2,655USD£2,067GBP
- Report
- October 2023
- 360 Pages
Global
From €2366EUR$2,583USD£2,011GBP
€3380EUR$3,690USD£2,873GBP
- Report
- February 2023
- 280 Pages
Global
From €2289EUR$2,499USD£1,946GBP
€3270EUR$3,570USD£2,779GBP
- Report
- September 2022
- 233 Pages
Global
From €2289EUR$2,499USD£1,946GBP
€3270EUR$3,570USD£2,779GBP
- Report
- July 2022
- 275 Pages
Global
From €2289EUR$2,499USD£1,946GBP
€3270EUR$3,570USD£2,779GBP
- Report
- February 2022
- 227 Pages
Global
From €2380EUR$2,598USD£2,023GBP
€3400EUR$3,712USD£2,890GBP
- Book
- April 2023
- 560 Pages
- Book
- October 2022
- 416 Pages
- Book
- September 2022
- 208 Pages
- Book
- April 2021
- 528 Pages
- Book
- March 2020
- 296 Pages
- Book
- March 2018
- 1134 Pages
- Book
- October 2014
- 384 Pages
- Book
- April 2012
- 360 Pages
- Book
- July 2022
- 256 Pages
- Book
- March 2016
- 544 Pages
- Book
- November 2012
- 408 Pages
- Book
- May 2012
- 726 Pages

The Bioscience market is a subset of the Biotechnology industry, which focuses on the application of living organisms and biological systems to develop products and services. It includes the development of new drugs, medical devices, diagnostics, and agricultural products. Bioscience also encompasses the use of biotechnology to create new materials, such as bioplastics, and to develop new processes, such as bioremediation.
Bioscience companies are typically involved in research and development, manufacturing, and marketing of products and services. They may also provide consulting services to other companies in the biotechnology industry. Many bioscience companies are involved in the development of new technologies, such as gene editing and synthetic biology.
Some of the major companies in the Bioscience market include Amgen, Biogen, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Bayer, Celgene, and Sanofi. Show Less Read more